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Introduction: Bariatric surgery is a well-received treatment for obesity with maximal
weight loss at 12–36 months postoperatively. We investigated the effect of early
bariatric surgery on weight reduction of Chinese patients in accordance with their
preoperation characteristics.
Materials and Methods: Altogether, 409 patients with obesity from a prospective
cohort in a single bariatric center were enrolled retrospectively and evaluated for up to
4 years. Measurements obtained included surgery type, duration of diabetic condition,
besides the usual body mass index data tuple. Weight reduction was expressed as
percent total weight loss (%TWL) and percent excess weight loss (%EWL).
Results: RYGB or SG were performed laparoscopically without mortality or
complications. BMI generally plateaued at 12 months, having decreased at a mean
of 8.78 kg/m2. Successful weight loss of >25% TWL was achieved by 35.16, 49.03,
39.22, 27.74, 20.83% of patients at 6, 12, 24, 36, and 48 months after surgery. Overall,
52.91% of our patients had lost 100% of their excess weight at 12months, although there
was a rather wide range among individuals. Similar variability was revealed in women of
child-bearing age.
Conclusion: Chinese patients undergoing bariatric surgery tend to achieve maximal
weight loss and stabilization between 12 and 24months postoperatively, instead of at>2
years. The finding of the shorter stabilization interval has importance to earlier intervention
of weight loss related conditions and women’s conception planning.
Keywords: bariatric surgery, Chinese patients, weight reduction, trend, follow up
INTRODUCTION
Obesity is a chronic health condition that is becoming a global issue. The World Health
Organization stated in 2016 that more than 1.9 billion adults were overweight, and more than 650
million were obese. Besides lifestyle intervention andmedication, bariatric surgery has been proved
to be a safe, effective, and durable procedure for weight loss among morbidly obese patients (1).
In addition, a number of comorbidities including essential hypertension, type 2 diabetes mellitus,
hyperlipidemia, bronchial asthma, obstructive sleep apnea, and osteoarthritis can be ameliorated or
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even resolved following bariatric surgery. In China, the number
of bariatric operations conducted has increased from around
4,000 as of the previous 5 year period to more than 10,000 during
the past 5 years (2).
In western countries, research evidences support the
consensus that postoperative body weight decreases to a
trough at 12–36 months after bariatric surgery (3–5). However,
there is currently no published investigation on standardized
weight loss after bariatric surgery in Asian settings, except a
few studies in Japan and Singapore showed that the average
percent total weight loss (%TWL) following bariatric surgery
was 20–25% within the first 3 years (6, 7). On account of
differences in the baseline body height and weight, and body
composition, it is not completely grounded to interpret the
weight loss on the Asian communities according to westerner
physical standards.
The degree of weight loss and the time when it most likely
occurs after bariatric surgery has been insufficiently addressed
in China. In addition, we recognized in our patients that
women who suffer from obesity-related infertility are more
likely to have unplanned pregnancies within the first year
following bariatric procedure. These altogether necessitate the
establishment of the timing of maximal weight reduction during
preoperative counseling. Patients who gain a realistic expectation
of weight loss tend to stick to lifestyle changes and better
cooperate with medical intervention, leading to uneventful
recovery and satisfactory (8). To fulfill the need, we examined
the up to 4 years’ weight loss responses in Chinese patients
following bariatric surgery according to their body mass index
(BMI), age, sex, surgery type, and duration of type 2 diabetes
mellitus (T2DM).
METHODS
We retrospectively reviewed the medical records of 409 patients
who had undergone RYGB between February 2011 and August
2018. The Human Research Review Board of our institution
approved the study and all patients provided their written
informed consent. The study was conducted in accordance
with the principles of the Declaration of Helsinki. Our
previous studies focused on the improved renal, respiratory,
and reproductive function after surgery (9–13). The present
study includes bariatric surgery patients who underwent at
least one follow-up evaluation during the first year after their
surgery. Exclusion criteria included missing preoperative BMI
record, unknown surgery type, death, and/or the presence of
surgical complications.
Altogether, 409 patients were enrolled in the study (252
women, representing 61.6%). Among them, 227 underwent
Roux-en-Y gastric bypass (RYGB) (55.5%), and the rest
underwent sleeve gastrectomy (SG). Data were collected
concerning the patients’ demographic data, including their
age and sex, T2DM diagnosis, type of surgery, initial BMI,
and postoperative weight loss for up to 4 years (Table 1).
Postoperative weight loss was expressed using the postoperative
BMI, change in BMI, %TWL and %EWL.
TABLE 1 | Baseline Characteristics.
Parameter (n = 409) Value
BMI, kg/m2, Mean ± SD (range) 34.37 ± 6.25 (25.5,67.5)
BMI group, n (%)
25–27.5 kg/m2 22 (5.4%)
27.5–32.5 kg/m2 177 (43.3%)
32.5–37.5 kg/m2 104 (25.4%)
37.5 kg/m2 and above 106 (25.9%)
Male sex, n (%) 157 (38.4%)
T2DM duration, n (%)
Non-diabetic 90 (22.0%)
0–5 years 168 (41.1%)
5–10 years 91 (22.2%)
10–15 years 43 (10.5%)
above 15 years 17 (4.2%)
Age, yrs, Mean ± SD 42.43 ± 13.27
Age, n (%)
18–45 235 (57.5%)
45–60 118 (28.9%)
60 and above 56 (13.7%)
RYGB surgical type, n (%) 227 (55.5%)
BMI, body mass index; T2DM, type 2 diabetes mellitus; RYGB, Roux-en-Y gastric bypass.
Statistical Analyses
IBM SPSS Statistics software Version 20.0 (IBM Inc., Armonk,
NY, USA) was used to analyze the data. Continuous data
were analyzed for normality using the Shapiro–Wilks test.
Differences between values were analyzed using the unpaired t-
test (normal data), paired t-test (normal data), Mann–Whitney
test (unpaired, non-normal data), or the Wilcoxon matched
pairs test (non-normal data). A value of p < 0.05 indicated
statistical significance.
RESULTS
Detailed characteristics of our cohort are shown inTable 1. There
were more female than male patients (252 vs. 157). No patients
had a BMI <25 kg/m2 (overweight), and there were 12 patients
whose BMIs were >50 kg/m2 (super morbidly obese) at the time
of their surgery. In all, 319 (78%) patients were diagnosed with
T2DM preoperatively. More patients (182 vs. 227) underwent
RYGB than SG.
Postoperative changes in the BMI for up to 4 years are shown
in Figure 1. The patients’ BMI generally plateaued at 12 months,
then decreased at a rate of 8.78 kg/m2. Following a slight rebound,
an insignificant downward trend was observed around the mid-
term, with the BMI decreasing to ∼25 kg/m2. Weight loss of
>20% TWL was achieved by 75.62, 64.66, 57.42, and 50.83%
of patients at 12, 24, 36, and 48 months after surgery. Up to
53.74% of our patients lost more than 100% of their excess weight
(compared with a BMI of 25 kg/m2) at 12 months. Although the
mean weight loss stabilized at ∼24 kg at 12 months, there was
wide variability among the individual values, especially between
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FIGURE 1 | Postoperative changes of 1BMI, %TWL, and %EWL. Results are shown in mean ± SEM.
the two surgical types. As can be seen from Table 2, weight loss
after SG rebounded at 3 years after surgery, whereas after RYGB
the weight loss was maintained.
Patients were also divided into groups based on certain
characteristics to explore other possibilities (Figure 2). For
example, there was no significant difference between the sexes,
although the female patients had generally lost more weight
than the male patients at the mid-term point. In addition, post-
RYGB weight loss followed a general pattern, whereas post-LSG
weight loss fluctuated dramatically during the 3 years after the
surgery. Divided into groups according to the preoperative BMI,
patients with higher BMIs tended to lose more weight, although
in a temperate slope, with the body weight dropping to its
lowest 2 years postoperatively (vs. 1 year in other groups). Non-
diabetic patients were more likely to have a significant weight
rebound, and patients who had been diagnosed with T2DM for
more than 15 years tended to face weight rebound as early as 6
months postoperatively.
Themost common recipients of bariatric surgery were women
of child-bearing age, accounting for 35.70% of our cohort (146
cases). Their mean BMI decreased from a baseline of 35.69
kg/m2 to an ideal 25.23 kg/m2 at 12 months and remaining
at that level for 3 years postoperatively. Of these cases, we
have also observed 17 pregnancies following bariatric surgery
that result in different outcomes due to surgery-to-conception
(S-C) interval. Two pregnancies were electively terminated
during the first trimester for non-medical reasons. Five
resulted in spontaneous abortions (defined as loss of pregnancy
before 20 wk’s gestation). The remaining 10 were carried
to delivery.
DISCUSSION
This attempt to explore common bariatric weight loss criteria for
Chinese patients showed that the body weight of bariatric surgery
patients decreased sharply during the first 12–24 months, instead
of at >2 years. It then stabilized unless the patient was non-
diabetic, underwent SG, or had a high preoperative BMI, all of
which make relapse more likely.
It is of interest to note that, the longer the patient’s history
of T2DM, the more likely it is that the body weight will
decrease unsatisfactorily (84.7% for T2DM duration >5 years),
if not rebound. This might be due to the different composition
of body fat. For example, in a comparison with their BMI-
matched normoglycemic counterparts, patients with T2DM have
increased hepatic and pancreatic fat, which causes a severe
systemic inflammatory state. A conclusive explanation for this
phenomenon, however, requires further study.
Comparison of the surgical effects of the gold standard RYGB
vs. the relatively new, yet predominating, SG has become a
topic of debate. Our data suggest that patients who undergo SG
have a significantly higher BMI than those who undergo RYGB.
Both groups plateaued at 12 months, but the SG group then
relapsed by a mean 3.4 kg/m2 3 years later. This conclusion
differs from that derived in western countries, where plateaus
usually start at 18 months, probably because of the higher
baseline body weight and different dietary preferences. Long-
term evidence of the effectiveness of SG remains sparse, although
short- to medium-term results suggest that SG may not be
inferior to RYGB (14). Our results may be biased because of
a larger drop-off in the follow-up of our SG patients (35.5%
less than in the RYGB group). Also, because data were collected
retrospectively in our study, some of the criteria selected were
strongly related to whether SG was performed, including the
duration of diabetes and baseline BMI. To justify the use
of SG, randomized, controlled trials or cohort studies will
be necessary to examine its benefit. In addition, a model
that can better represent the effectiveness of bariatric surgery
should be created, thereby neutralizing baseline differences that
cannot be obviated.
Additionally, because most bariatric surgery is performed in
women of reproductive age, defining the ideal interval between
surgery and pregnancy is an emerging issue, which is partly
based on the remission of obesity, which remains controversial
in the present literature (15). Especially obese women in their
late thirties who have failed many attempts to lose weight may
look forward to a shorter interval for the good of both themselves
and their children (16). Our research has indicated that women of
reproductive age attain body weight stability at 12 months, which
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TABLE 2 | Reduction in BMI after surgery.
1-m post-op 3-m post-op 6-m post-op 1-y post-op 2-y post-op 3-y post-op 4-y post-op
n 242 322 347 361 232 155 120
Follow-up rate 59% 79% 85% 88% 57% 38% 29%
BMI, kg/m2 29.07 ± 4.33 27.20 ± 4.40 26.01 ± 4.29 25.28 ± 3.88 25.40 ± 3.86* 25.68 ± 3.83* 25.58 ± 3.84*
RYGB 27.84 ± 3.18 25.59 ± 2.90 24.50 ± 3.03 24.08 ± 2.91 24.66 ± 3.34* 25.16 ± 3.34* 25.26 ± 3.64*
SG 33.30 ± 5.04 30.27 ± 5.09 28.26 ± 4.87 26.89 ± 4.42 27.38 ± 4.54* 28.46 ± 5.04 27.98 ± 4.59*
1BMI, kg/m2 3.85 ± 1.22 6.26 ± 1.78 7.97 ± 2.89 8.75 ± 3.72 7.88 ± 3.66 6.94 ± 3.07 6.42 ± 2.85
RYGB 3.65 ± 1.16 5.77 ± 1.52 6.84 ± 2.05 7.18 ± 2.24 6.81 ± 2.60 6.34 ± 2.45 6.07 ± 2.52
SG 4.53 ± 1.21 7.21 ± 1.86 9.67 ± 3.14 10.87 ± 4.22 10.75 ± 4.47 10.18 ± 4.01 8.98 ± 3.79
%TWL 11.65 ± 3.11 18.63 ± 3.92 23.11 ± 5.88 25.12 ± 7.28 23.16 ± 8.13 20.96 ± 7.41 19.86 ± 7.76
RYGB 11.55 ± 3.22 18.32 ± 4.10 21.67 ± 5.53 22.81 ± 6.15 21.47 ± 7.14 20.01 ± 7.40 19.30 ± 7.40
SG 12.00 ± 2.71 19.22 ± 3.50 25.27 ± 5.75 28.24 ± 7.54 27.72 ± 8.90 26.10 ± 8.63 24.02 ± 9.29
%EWL 58.88 ± 25.04 78.46 ± 22.31 85.71 ± 18.60 88.48 ± 16.43 85.72 ± 20.03 83.50 ± 22.85 82.33 ± 24.02
RYGB 64.15 ± 24.43 85.59 ± 18.57 91.27 ± 15.20 92.23 ± 14.28 87.64 ± 19.63 85.06 ± 22.34 83.48 ± 23.56
SG 40.83 ± 17.79 64.85 ± 22.59 77.31 ± 20.11 83.44 ± 17.79 80.55 ± 20.35 75.08 ± 24.19 73.81 ± 26.56
Percentage of
follow-up patients
who reached
≥50%EWL
11.98% 38.20% 49.86% 52.91% 51.29% 52.90% 50.83%
Percentage of
follow-up patients
who reached
≥25%TWL
0.41% 5.28% 35.16% 49.03% 39.22% 27.74% 20.83%
%TWL = Initial BMI−Final BMIInitial BMI × 100%, % EWL =
Initial BMI−Final BMI
Initial BMI−Ideal BMI × 100%, *P > 0.05 (vs. previous visit).
FIGURE 2 | Postoperative changes of BMI in all patients and in different groups. (A) Mean BMI change after bariatric surgery; (B) Mean BMI change in different
gender groups; (C) Mean BMI change in different surgery type groups; (D) Mean BMI change in different initial BMI groups; (E) Mean BMI change in different T2DM
duration groups; (F) Mean BMI change in different age groups. Results are shown in mean ± SEM.
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indicates a mesomeric state suitable for pregnancy. Previous
studies have shown that, in obese women with polycystic ovary
syndrome, hormones such as estrogen and progestogen achieve
a normalized balance as early as 3 months after bariatric
surgery, which has led to unplanned pregnancies (17). Therefore,
guidelines for bariatric surgery often suggest that pregnancy be
avoided during the first 18–24 months postoperatively—which is
generally based on consensus instead of evidence (18). However,
some studies have shown that there were almost no maternal or
neonatal complications in women who became pregnant even
within 6 months from the surgery (18, 19). In Asian settings,
some research should be dedicated to determining whether the
period between surgery and pregnancy can be shortened, and by
how much. With our current cohort, the number of pregnancy
cases was too small, thusmore ought to bemonitored in extended
studies, in order to draw a rigorous conclusion over suggestions
for conception.
The findings of this study have the potential to improve
the perioperative care of patients undergoing bariatric surgery,
highlighting areas for improvement in the follow-up protocol. As
can be seen, although international standards (for RYGB) were
followed regarding the follow-up routine, we could not identify
a more precise “lowest body-weight period,” which is vital to
prevent regaining the lost weight. Therefore, more frequent
monthly measurements between the 6 and 12 month follow-up
evaluations can be scheduled and carried further beyond the first
year. With this protocol, we hope to be able to identify patients
who are at high risk for treatment failure at an early stage, so help
can be provided promptly. Studies have reported the importance
of developing good exercise and eating habits during the early
postoperative period (20). Appropriate support can also be given
to patients suffering frommental health issues such as depression
or anxiety (21, 22).
There are some limitations of our study. First, as a
retrospective trial, there is a risk of reporting and selection
bias. To lessen the impact, data were collected prospectively,
and all patients who met the inclusion criteria were enrolled
consecutively in the study. Second, there was a large dropout
rate, especially after 2 years postoperatively. More attention
should be given to long-term follow-up, including the use
of specialized personnel, standardized questionnaires, and
professional databases. Third, the criteria we used to divide
patients into groups were not sufficiently rigid (e.g., the surgery
type may be dependent on diabetes duration and the BMI). The
most essential criteria will be established in future studies.
CONCLUSIONS
Patients in a Chinese population achieved maximal weight loss
and stabilization most probably between 12 and 24 months after
surgery, instead of at >2 years. Further patient follow-up should
include the time point of 18 month after surgery to establish
more precise monthly time frames. The finding of the shorter
stabilization interval is meaningful to earlier intervention of
weight loss related conditions and women’s conception planning.
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